Found: 17
Select item for more details and to access through your institution.
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. e211, doi. 10.1111/bjh.16629
- By:
- Publication type:
- Article
Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 4, p. 619, doi. 10.1111/bjh.12885
- By:
- Publication type:
- Article
Poor peripheral blood stem cell mobilization affects long‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.
- Published in:
- Journal of Clinical Apheresis, 2018, v. 33, n. 1, p. 29, doi. 10.1002/jca.21556
- By:
- Publication type:
- Article
A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 1/2, p. 46, doi. 10.1159/000455146
- By:
- Publication type:
- Article
Genomic Instability Profiles at the Single Cell Level in Mouse Colorectal Cancers of Defined Genotypes.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1267, doi. 10.3390/cancers13061267
- By:
- Publication type:
- Article
Phthalate-Induced Liver Protection against Deleterious Effects of the Th1 Response: A Potentially Serious Health Hazard.
- Published in:
- PPAR Research, 2007, p. 1, doi. 10.1155/2007/49671
- By:
- Publication type:
- Article
Id2 controls specification of Lgr5<sup>+</sup> intestinal stem cell progenitors during gut development.
- Published in:
- EMBO Journal, 2017, v. 36, n. 7, p. 869, doi. 10.15252/embj.201694959
- By:
- Publication type:
- Article
MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S427, doi. 10.1016/S2152-2650(21)01953-4
- By:
- Publication type:
- Article
Poster: MM-186: HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD): Subgroup Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S250, doi. 10.1016/S2152-2650(21)01573-1
- By:
- Publication type:
- Article
Activity of Melflufen in RR MM Patients with Extramedullary Disease in the Phase 2 HORIZON Study (OP-106): Promising Results in a High-Risk Population.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e352, doi. 10.1016/j.clml.2019.09.582
- By:
- Publication type:
- Article
ANCHOR (OP-104) Study of Melflufen and Dexamethasone Plus Bortezomib or Daratumumab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to an IMiD and/or a Proteasome Inhibitor (PI): Phase 1 Update.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S326, doi. 10.1016/j.clml.2019.07.313
- By:
- Publication type:
- Article
HORIZON (OP-106) Study of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S329, doi. 10.1016/j.clml.2019.07.318
- By:
- Publication type:
- Article
On Bayesian methods of exploring qualitative interactions for targeted treatment.
- Published in:
- Statistics in Medicine, 2012, v. 31, n. 28, p. 3693, doi. 10.1002/sim.5429
- By:
- Publication type:
- Article
Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02650-z
- By:
- Publication type:
- Article
Kinetic Basis of the Bifunctionality of SsoII DNA Methyltransferase.
- Published in:
- Molecules, 2018, v. 23, n. 5, p. 1192, doi. 10.3390/molecules23051192
- By:
- Publication type:
- Article
Effect of melphalan 140 mg/m<sup>2</sup> vs 200 mg/m<sup>2</sup> on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.
- Published in:
- Clinical Transplantation, 2016, v. 30, n. 8, p. 894, doi. 10.1111/ctr.12762
- By:
- Publication type:
- Article
Molecular Monitoring of BCR-ABL Transcripts in Patients With Chronic Myelogenous Leukemia: Is High Sensitivity of Clinical Value?
- Published in:
- Current Hematologic Malignancy Reports, 2010, v. 5, n. 2, p. 88, doi. 10.1007/s11899-010-0046-x
- By:
- Publication type:
- Article